Yuhui Tang

2.1k total citations · 4 hit papers
28 papers, 1.4k citations indexed

About

Yuhui Tang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuhui Tang has authored 28 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 10 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuhui Tang's work include RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yuhui Tang is often cited by papers focused on RNA modifications and cancer (9 papers), Ferroptosis and cancer prognosis (8 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Yuhui Tang collaborates with scholars based in China, United States and Hong Kong. Yuhui Tang's co-authors include Jindong Xie, Yutian Zou, W. H. Tian, Xinpei Deng, Hailin Tang, Shaoquan Zheng, Xiaoming Xie, Linyu Wu, Chau‐Wei Wong and Xueqi Ou and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Yuhui Tang

28 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leveraging diverse cell-death patterns to predict the prognosis and drug sensitivity of triple-negative breast cancer patients after surgery

2022 248 citations Yutian Zou, Jindong Xie et al. profile →
The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer

2022 191 citations Yutian Zou, Feng Ye et al. Advanced Science profile →
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer

2022 167 citations Yutian Zou, Shaoquan Zheng et al. Nature Communications profile →
Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies

2024 50 citations Jindong Xie, Xinpei Deng et al. SHILAP Revista de lepidopterología profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuhui Tang China	18	913	554	471	430	245	28	1.4k
Xinpei Deng China	22	1.1k 1.2×	666 1.2×	474 1.0×	504 1.2×	281 1.1×	51	1.7k
Jindong Xie China	23	1.1k 1.2×	641 1.2×	576 1.2×	576 1.3×	311 1.3×	55	1.8k
W. H. Tian China	16	666 0.7×	415 0.7×	421 0.9×	360 0.8×	194 0.8×	25	1.1k
Gui‐Yan Xie China	7	870 1.0×	463 0.8×	506 1.1×	381 0.9×	315 1.3×	13	1.4k
Ya‐Ru Miao China	6	822 0.9×	432 0.8×	530 1.1×	419 1.0×	356 1.5×	6	1.4k
Zhiliang Lu China	23	1.1k 1.2×	788 1.4×	368 0.8×	467 1.1×	208 0.8×	38	1.6k
Diego M. Marzese United States	25	1.2k 1.3×	608 1.1×	276 0.6×	507 1.2×	203 0.8×	75	1.7k
Shaoquan Zheng China	26	1.4k 1.5×	1.0k 1.8×	537 1.1×	646 1.5×	262 1.1×	51	2.2k
Siyuan Weng China	18	717 0.8×	442 0.8×	530 1.1×	523 1.2×	314 1.3×	75	1.5k

Countries citing papers authored by Yuhui Tang

Since Specialization

Citations

This map shows the geographic impact of Yuhui Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuhui Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuhui Tang more than expected).

Fields of papers citing papers by Yuhui Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuhui Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuhui Tang. The network helps show where Yuhui Tang may publish in the future.

Co-authorship network of co-authors of Yuhui Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuhui Tang. A scholar is included among the top collaborators of Yuhui Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuhui Tang. Yuhui Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Yuhui, et al.. (2025). Crosstalk between Gut Microbiota and Cancer Immunotherapy: Present Investigations and Future Perspective. Research. 8. 600–600. 12 indexed citations

Tang, Yuhui, Jindong Xie, Liulu Zhang, et al.. (2025). Multi-omics analyses of the heterogenous immune microenvironment in triple-negative breast cancer implicate UQCRFS1 potentiates tumor progression. Experimental Hematology and Oncology. 14(1). 85–85. 1 indexed citations

Xie, Yi, Jindong Xie, Guoxian Huang, et al.. (2025). Isoliquiritigenin reduces brain metastasis by circNAV3-ST6GALNAC5-EGFR axis in triple-negative breast cancer. Cancer Letters. 624. 217734–217734. 10 indexed citations

Tang, Yuhui, Hao Chen, Junsheng Zhang, et al.. (2025). The EGR1-mediated lncRNA TENM3-AS1 potentiates gastric cancer metastasis via reprogramming fatty acid metabolism. Molecular Cancer. 24(1). 165–165. 1 indexed citations

Tan, Yeru, Jingping Yuan, Hailin Tang, et al.. (2024). circLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Cancer Letters. 592. 216907–216907. 23 indexed citations

Wu, Linyu, Shanshan Huang, W. H. Tian, et al.. (2024). PIWI-interacting RNA-YBX1 inhibits proliferation and metastasis by the MAPK signaling pathway via YBX1 in triple-negative breast cancer. Cell Death Discovery. 10(1). 7–7. 25 indexed citations

Xie, Jindong, Xinpei Deng, Yi Xie, et al.. (2024). Multi‐omics analysis of disulfidptosis regulators and therapeutic potential reveals glycogen synthase 1 as a disulfidptosis triggering target for triple‐negative breast cancer. SHILAP Revista de lepidopterología. 5(3). e502–e502. 44 indexed citations

Xie, Jindong, Xinpei Deng, Yuhui Tang, et al.. (2024). Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies. SHILAP Revista de lepidopterología. 3(1). e156–e156. 50 indexed citations breakdown →

Tian, W. H., Yuhui Tang, Jindong Xie, et al.. (2023). AURKAIP1 actuates tumor progression through stabilizing DDX5 in triple negative breast cancer. Cell Death and Disease. 14(12). 790–790. 17 indexed citations

10.

Xie, Jindong, Wei Deng, Xinpei Deng, et al.. (2023). Single-cell histone chaperones patterns guide intercellular communication of tumor microenvironment that contribute to breast cancer metastases. Cancer Cell International. 23(1). 311–311. 18 indexed citations

11.

Xie, Jindong, Xinpei Deng, Yuhui Tang, et al.. (2023). Circular RNA: A promising new star of vaccine. Journal of Translational Internal Medicine. 11(4). 372–381. 70 indexed citations

12.

Tian, W. H., Yuhui Tang, Yanan Kong, et al.. (2023). Novel Implication of the Basement Membrane for Breast Cancer Outcome and Immune Infiltration. International Journal of Biological Sciences. 19(5). 1645–1663. 20 indexed citations

13.

Xie, Jindong, Xinpei Deng, Yuhui Tang, et al.. (2023). Advances in artificial intelligence to predict cancer immunotherapy efficacy. Frontiers in Immunology. 13. 1076883–1076883. 63 indexed citations

14.

Zheng, Shaoquan, Jie‐Ying Liang, Yuhui Tang, et al.. (2023). Dissecting the role of cancer‐associated fibroblast‐derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single‐cell transcriptomic study. Clinical and Translational Medicine. 13(2). e1189–e1189. 42 indexed citations

15.

Wang, Zehao, Lu Yang, Peng Wu, et al.. (2022). The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin. Molecular Cancer. 21(1). 29–29. 118 indexed citations

16.

Zou, Yutian, Feng Ye, Yanan Kong, et al.. (2022). The Single‐Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in Liver and Brain Metastases of Breast Cancer. Advanced Science. 10(5). e2203699–e2203699. 191 indexed citations breakdown →

17.

Zou, Yutian, Shaoquan Zheng, Xinhua Xie, et al.. (2022). N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nature Communications. 13(1). 2672–2672. 167 indexed citations breakdown →

18.

Xie, Jindong, Junsheng Zhang, W. H. Tian, et al.. (2022). The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance. International Journal of Molecular Sciences. 23(24). 15647–15647. 39 indexed citations

19.

Xie, Jindong, W. H. Tian, Yuhui Tang, et al.. (2022). Establishment of a Cell Necroptosis Index to Predict Prognosis and Drug Sensitivity for Patients With Triple-Negative Breast Cancer. Frontiers in Molecular Biosciences. 9. 834593–834593. 35 indexed citations

20.

Zou, Yutian, Jindong Xie, W. H. Tian, et al.. (2022). Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 839986–839986. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact